NAS:QTNT (UK) Also trade in: Germany

Quotient Ltd

$ 10.47 0.01 (0.1%)
Volume: 155,243 Avg Vol (1m): 375,246
Market Cap $: 692.88 Mil Enterprise Value $: 721.24 Mil
P/E (TTM): 0.00 P/B: 402.77
Earnings Power Value -12.34
Net Current Asset Value -0.91
Tangible Book 0.02
Projected FCF -9.39
Median P/S Value 5.24
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 3.1/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.77
Cash-To-Debt range over the past 10 years
Min: 0.25, Med: 0.99, Max: 2.52
Current: 0.77
0.25
2.52
Equity-to-Asset 0.01
Equity-to-Asset range over the past 10 years
Min: -1.79, Med: -0.17, Max: 0.39
Current: 0.01
-1.79
0.39
Debt-to-Equity 71.87
Debt-to-Equity range over the past 10 years
Min: -9.21, Med: -0.33, Max: 71.87
Current: 71.87
-9.21
71.87
Debt-to-EBITDA -1.86
Debt-to-EBITDA range over the past 10 years
Min: -1.87, Med: -1.14, Max: -0.53
Current: -1.86
-1.87
-0.53
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.69
DISTRESS
GREY
SAFE
Beneish M-Score -2.81
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -197.71%
WACC 5.7%

Profitability & Growth : 2/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -271.01
Operating Margin range over the past 10 years
Min: -333.19, Med: -161.42, Max: -31.25
Current: -271.01
-333.19
-31.25
Net Margin % -361.73
Net Margin range over the past 10 years
Min: -382.73, Med: -182.91, Max: -32.8
Current: -361.73
-382.73
-32.8
ROA % -67.75
ROA range over the past 10 years
Min: -107.37, Med: -70.16, Max: -33.89
Current: -67.75
-107.37
-33.89
ROC (Joel Greenblatt) % -147.32
ROC (Joel Greenblatt) range over the past 10 years
Min: -310.99, Med: -149.28, Max: -113.04
Current: -147.32
-310.99
-113.04
3-Year Total Revenue Growth Rate 16.30
3-Year Revenue Growth Rate range over the past 10 years
Min: -21.4, Med: -9.3, Max: 25.3
Current: -17.5
-21.4
25.3
3-Year Total EBITDA Growth Rate -12.80
3-Year EBITDA Growth Rate range over the past 10 years
Min: -107.5, Med: -46.95, Max: 20
Current: 20
-107.5
20
3-Year EPS w/o NRI Growth Rate -3.50
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: -453.4, Med: 8.45, Max: 62.9
Current: -3.5
-453.4
62.9

» QTNT's 30-Y Financials

Financials (Next Earnings Date: 2019-08-07)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:QTNT

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Medical Diagnostics & Research    NAICS : 541380    SIC : 2835
Compare HKSE:02393 SZSE:300639 NAS:VIVO OHEL:REG1V SHSE:603716 NAS:SRDX NAS:HSKA NAS:RDNT SZSE:300289 BSP:AALR3 AMEX:SENS BSP:PARD3 NAS:OXFD SZSE:002932 NSE:THYROCARE XBRU:BCART LSE:IDHC XPAR:LBIRD OSTO:IMMNOV SZSE:300396
Traded in other countries U4W.Germany
Address B1, Business Park Terre Bonne, Route de Crassier 13, Eysins, CHE, 1262
Quotient Ltd is a commercial-stage diagnostics company. It is involved in the business of provision of tests with an initial focus on blood grouping and serological disease screening. The company develops and commercializes Mosaiq automation platform. Its product portfolio includes Red cell reagents, Antisera, Specialty products, Specialty kits etc. The firm operates in Edinburgh, Scotland, Eysins, Switzerland and Newton, Pennsylvania. It derives the majority of its revenue from the United States.

Ratios

Current vs industry vs history
PB Ratio 402.77
PB Ratio range over the past 10 years
Min: 4.51, Med: 14.66, Max: 420.38
Current: 402.77
4.51
420.38
PS Ratio 19.48
PS Ratio range over the past 10 years
Min: 4.33, Med: 9.74, Max: 20.32
Current: 19.48
4.33
20.32
EV-to-EBIT -9.16
EV-to-EBIT range over the past 10 years
Min: -9.9, Med: -5.4, Max: -2.2
Current: -9.16
-9.9
-2.2
EV-to-EBITDA -10.90
EV-to-EBITDA range over the past 10 years
Min: -11.2, Med: -6.1, Max: -2.5
Current: -10.9
-11.2
-2.5
EV-to-Revenue 24.80
EV-to-Revenue range over the past 10 years
Min: 4.5, Med: 11.8, Max: 25.3
Current: 24.8
4.5
25.3
Current Ratio 4.59
Current Ratio range over the past 10 years
Min: 0.9, Med: 2.06, Max: 4.59
Current: 4.59
0.9
4.59
Quick Ratio 3.98
Quick Ratio range over the past 10 years
Min: 0.82, Med: 1.4, Max: 3.98
Current: 3.98
0.82
3.98
Days Inventory 330.51
Days Inventory range over the past 10 years
Min: 71.9, Med: 248.09, Max: 521.37
Current: 330.51
71.9
521.37
Days Sales Outstanding 41.94
Days Sales Outstanding range over the past 10 years
Min: 35.85, Med: 42.11, Max: 45.2
Current: 41.94
35.85
45.2
Days Payable 125.75
Days Payable range over the past 10 years
Min: 114.65, Med: 210.83, Max: 362.91
Current: 125.75
114.65
362.91

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -29.30
3-Year Share Buyback Rate range over the past 10 years
Min: -38.9, Med: -24.05, Max: 0
Current: -29.3
-38.9
0

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 523.50
Price-to-Tangible-Book range over the past 10 years
Min: 4.88, Med: 252.72, Max: 623.33
Current: 523.5
4.88
623.33
Price-to-Median-PS-Value 2.00
Price-to-Median-PS-Value range over the past 10 years
Min: 0.79, Med: 0.95, Max: 2.03
Current: 2
0.79
2.03
Earnings Yield (Joel Greenblatt) % -10.94
Earnings Yield (Greenblatt) range over the past 10 years
Min: -45.6, Med: -18.4, Max: -10.1
Current: -10.94
-45.6
-10.1

More Statistics

Revenue (TTM) (Mil) $ 29.13
EPS (TTM) $ -1.95
Beta 0.39
Volatility % 67.66
52-Week Range $ 5.52 - 11.15
Shares Outstanding (Mil) 64.97

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA N
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y